Merck held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3bn
- Posted on June 2, 2025
- By Financial Times
- 4 Views
Merck held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3bn
US pharmaceuticals group has been looking to rebuild its pipeline before crucial cancer drug comes off-patent
